Do mast cells worsen deep vein thrombosis?
Dr Alexander Brill (lead researcher)
University of Birmingham
Start date: 01 March 2014 (Duration 3 years)
The role of mast cells in deep vein thrombosis
Mast cells form an important part of our immune system, but may worsen or play a part in the onset of deep-vein thrombosis (DVT*). In DVT, mast cells appear to cause the blood vessel lining endothelial cells to encourage the formation of clots. Dr Alexander Brill from the University of Birmingham has been awarded a 3-year grant totalling £223,000 to look into the role of mast cells in DVT. Dr Brill’s previous research has shown that mice lacking mast cells had complete protection from DVT and less clot-forming activity by the endothelial cells. He is looking to build on this important early work, characterising further the role of mast cells in the development of DVT in mice. *DVT – where blood clots block blood flow in veins – can be catastrophic and life-threatening. Current ways to prevent or treat DVT can have unwanted side effects such as bleeding and so a complication-free approach is needed. Medicines that target the mast cells in patients with DVT could one day offer an effective and safe approach to tackling these blood clots.
Project details
| Grant amount | £237,315 |
|---|---|
| Grant type | Project Grants |
| Application type | Project Grant |
| Start Date | 01 March 2014 |
| Duration | 3 years |
| Reference | PG/13/60/30406 |
| Status | Complete |